Results Healthcare   |   Results International


Results Healthcare regularly hosts and attends events designed to help clients broaden both their understanding of major trends and issues

Selecting the right partner for growth: PE or Trade

Selecting the right partner for growth: PE or Trade

The rapid rise in private equity investment in technology, marketing services and healthcare in recent years has provided a really interesting alternative to founders seeking to de-risk, accelerate growth and find the right partner for the next phase of their development. There are some material differences – and similarities – between selling to a trade buyer and partnering with private equity, and understanding how they differ and what each brings to the table, is key to making the right choice. We are bringing together a panel of successful entrepreneurs that have had experience with both private equity and trade, to share their insights on what to expect from each and how to choose the right partner for you.

The event is designed for entrepreneurs / CEOs / founders / business owners, and we will focus on sharing practical and hard-earned advice on the following:

  • Choosing the right partner for you: PE or Trade
  • What each one brings to the table
  • What to expect post-deal
  • Different investment horizons
  • Preparation: differences between a PE vs Trade or dual-track process

You’ll have an opportunity to have your questions answered by an expert panel including…


Paul Kenyon, Co-Founder Avecto

Paul is the Co-Founder and former Co-CEO of Avecto (now BeyondTrust, owned by Bomgar). Paul brings a two-fold perspective to the panel having led Avecto through both a PE process and subsequent sale to the US enterprise software vendor, Bomgar. Paul co-founded Avecto in 2008, building it rapidly into a global leader in cybersecurity software. In 2015, the company raised $49 million investment from the US growth equity fund JMI Equity. Following this investment, Avecto continued its exceptional growth and was acquired by Bomgar in 2018. in 2018.

Dennis O’Brien, Co-Founder and CEO, Lucid Group

Dennis co-founded Lucid, a multi-award winning specialist provider of strategic medical communications services to global pharmaceutical companies, in 2007. Dennis and his co-founder grew the business to over 100 employees by mid-2017, and at that point secured a £11 million investment from one of the UK’s leading mid-market private equity investors, LDC, to support further growth and US expansion. Dennis has continued to grow the business since the investment and has made a number of acquisitions of other companies.

Rob Wood, Co-Founder and CEO, STEM 

Rob Wood co-founded STEM Marketing (now STEM Healthcare) in 2007, building it into the leading global provider of marketing and medical audits to pharmaceutical companies, with operations across 35 countries in Europe, the Americas and Asia, and consistent year-on-year growth of over 30%. In 2016, Rob led the company through sale to trade buyer UDG Healthcare, an LSE-listed global leader in healthcare services, in a deal worth up to £84m. Rob has continued to lead and build STEM within UDG since the transaction.

Register now before our limited spaces fill.


Event registration form - Selecting the right partner for growth

The information you submit will be added to our mailing list. We will never share your details with third parties. By completing this form you agree to our privacy policy.
  • This field is for validation purposes and should be left unchanged.



Regular Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office